My First Million · Episode Brief
3 Stories Of People Making Millions In Weird Ways
Three people making money in ways that shouldn't work — and one extended argument about whether prediction markets are gambling or the most honest information system ever built.
This episode opens with an unlikely anchor: Martha Stewart as a case study in personal-brand building. Sam and Shaan use her arc — television personality to convicted felon to improbable comeback — to argue something specific: that Martha was doing what the Hormozis and MrBeast do today, decades before the infrastructure existed to support it. She understood that being the product was the model, and she built a licensing empire around a single aesthetic identity. The fact that she nearly destroyed it with a $230,000 insider trading scandal is almost secondary to how rare it was for a woman to build that kind of media-to-product flywheel in 1990.
The Ozempic segment is brief but pointed. A researcher named Isaak posted findings suggesting GLP-1 agonists — the same drugs driving weight loss — appear to dramatically reduce sleep apnea and improve sleep quality in some patients. Sam and Shaan's reaction is less about the clinical details and more about what this means for adjacent industries: CPAP machine manufacturers, sleep clinics, and mattress companies should all be paying attention. There's a real business angle here about what happens to incumbents when a drug reshapes a behavioral category.
The Polymarket whale section is the episode's centerpiece. An anonymous trader (later identified as a French national named Theo) bet roughly $50M on Trump winning the 2024 election — and won. Sam and Shaan walk through the Chainalysis investigation, the coordination of wallets, and the philosophical question underneath it all: if you have better information than the market, is prediction market trading gambling or rational arbitrage? Vitalik Buterin's blog post arguing that prediction markets are "info finance" — a way for society to aggregate dispersed knowledge — becomes the episode's closing argument. It's a genuinely interesting frame, and the question of when superior information becomes unfair advantage is one that has no clean answer.
Key Ideas
- →Martha Stewart was running the Hormozi playbook in 1990 — personal brand as the core product, with licensing and merchandise as the revenue layer — but without the internet to distribute it.
- →GLP-1 drugs like Ozempic appear to have significant effects on sleep apnea, which could structurally threaten the CPAP and sleep clinic industries in ways the market hasn't priced yet.
- →The Polymarket whale Theo bet $50M on Trump's election victory with what appears to have been informational edge, not random speculation — raising questions about when prediction market trading is research-driven vs. gambling.
- →Vitalik Buterin's 'info finance' framing: prediction markets are useful not because they enrich traders but because they aggregate information no single institution can collect.
- →The coordination of multiple wallets in Theo's position suggests he was treating this as a portfolio trade, not a single bet — which is a different kind of risk management than most traders apply to event markets.
Worth Remembering
Sam's counterfactual: Martha Stewart would have been MFM's 'Billy of the Week' in 1999 — a genuine compliment that also captures how ahead of her time the business model was.
The Chainalysis slide showing how $50M was spread across multiple wallets in a way that masked the concentration of a single trader's position.
Shaan reading Vitalik's blog post live and reacting to the sentence 'prediction markets are a tool for truth-seeking' with visible skepticism before slowly agreeing.
The observation that sleep apnea treatment is a $6B industry and Ozempic's sleep effects were discovered almost accidentally through patient self-reporting.